![]() |
Image: Mitch Revs |
![]() |
Image: Michelle Lawson |
![]() |
Image: Mitch Revs |
![]() |
Image: Michelle Lawson |
BY DAKOTA TAIT
Researchers at the Hunter Medical Research Institute and University of Newcastle have made a breakthrough in treating late-stage melanoma.
Using a combination of two existing drug treatments, they've managed to significantly improve survival times for patients.
Professor Nikola Bowden says the results are exciting.
"This clinical trial was people with melanoma who are resistant to all our current treatments," she said.
"What we did was take really old chemotherapy drugs and repurpose them to treat the patients and then to put them back on their previous immunotherapy treatment."
"The combination has worked really well."
The team says it was able to re-sensitise cancer cells to immunotherapy, through the combination of Azacitidine and Carboplatin.
It's been investigating their potential since 2015, with 20 people taking part in the trial between 2017 and 2021.
The patients survived an average of 47 weeks, and four of the patients are still alive today.
A second stage of trials is now underway using updated immunotherapy drugs, and initial results suggest it could be even more promising.
"This group of patients have no other treatment options and have a very short prognosis usually," Prof Bowden said.
"It's an option for them, when all the other drugs have stopped working, and there's potential that it will work in other cancers as well."
![]() |
Image credit: Hunter Medical Research Institute. |
BY DAKOTA TAIT
An electric car has embarked on the first leg of a round trip of Australia on Friday, departing Newcastle for a journey largely powered by the sun.
The University of Newcastle team is attempting to cover just over 15,000 kilometres in a few months, aiming to cover around 130 kilometres a day.
The vehicle will be charged mostly by solar panels, though they'll use conventional charging points in urban areas.
Professor Paul Dastoor, Director of the Centre for Organic Electronics, says it's a chance to do away of some of the so-called 'range anxiety' around long-distance trips.
"We're taking an electric vehicle - a Tesla - anti-clockwise around Australia, charged by printed solar," he said. "The sort of lightweight renewable energy technology we've developed here at the University of Newcastle."
"It's our first opportunity to road-test printed solar. This journey is all about expanding people's appreciation of electric vehicles."
Each of the 18 printed solar sheets is 18 metres long and weighs 12 kilograms, but they will be rolled up and stored in the boot while the car's on the road.
It takes around six hours to charge the car for 160 kilometres of driving, but the team's estimated the charging costs for the entire trip at just $80.
The team will also be visiting schools around the country to deliver a STEM (Science, Technology, Engineering and Maths) Roadshow.
"It gives us an opportunity to actually test the technology we've developed and also to deliver an education program across Australia," Prof Dastoor said.
"Being able to go out to regional, rural, and outback schools, and talk to them about how the science they're learning in their classroom translates to university studies, to research, and then ultimately, technology that will change people's lives."
![]() |
Image credit: Charge Around Australia. |
BY DAKOTA TAIT
Citizen scientists are calling for more research into thermal pollution in the wake of a mass fish kill at Mannering Park in August.
The Environment Protection Authority (EPA) concluded earlier this week, the mass death was sparked when winds and cooler weather met the warmer water temperatures cause by the discharge of Vales Point Power Station, overturning the water column.
The Hunter Community Environment Centre (HCEC) agrees with the EPA's verdict, but argues it's a sign more research into the issue is needed.
Senior Researcher Paul Winn says it's already having an impact.
"That thermal pollution is already known to have caused the almost total loss of seagrass in Wyee Bay, and the EPA reacted to that loss, and reduced its thermal pollution," he said.
"But what we're mostly concerned about is the impact on the broader ecosystem - the impact on the fishing, on the fish species, and the species mix that we're going to get."
It's likely a number of tropical species attracted by or adapted to the warmer water in the bay were also shocked by the event.
The EPA says it has deployed a smart buoy at Wyee Point to monitor the lake, but the HCEC is pushing for a full study.
"When these power stations were built, they were built just to make power," Mr Winn said. "They didn't really care whether they were going to have an impact or not."
"Now I think people have moved since then, and we expect a lot more from our industries and we expect more from our regulators. We want to make sure these industrial plants are going to be able to continue to be operated, up until their closure date, in a safe manner."
Vales Point Power Station is due to close its doors in 2029, though Delta Electricity has indicated in the past it would seek to extend its lifespan.
Mr Winn says simply closing the station won't resolve the issue, however.
"At some stage this power station is going to close," he said. "And the concerns that we have for this closure is that this thermal pollution, these ecosystems have adapted to to some degree over the years, with the introduction of eagle rays and green turtles."
"If that thermal pollution is turned off when the power station closes, we're likely to see a much larger and broader fish kill, because those warmer adapted species aren't going to be able to survive any more."
"We need to reduce that thermal pollution over some period of time, to allow those species and those ecosystems to adapt, and that's currently not being contemplated by either the EPA or the power station."
![]() |
Image credit: Hunter Community Environment Centre. |
BY DAKOTA TAIT
A legless lizard found in the Hunter Valley has been identified as a brand new species.
The Hunter Valley Delma, discovered in 2012, was originally believed to be a new population of the Striped Delma.
But scientists at the Australian Museum, noticing the species had barred lips and wasn't as strongly striped, conducted genetic testing and confirmed the local lizard was a new species.
It's the first species of legless lizard endemic to New South Wales, but it's believed it could have evaded researchers for so long because it usually lives in burrows and under grass tussocks, and avoids contact with humans.
Scientists say the species is likely to be threatened, due to development, mining, and agriculture across the Hunter Valley.
![]() |
Image credit: Australian Museum. |
![]() |
Image credit: marine.nsw.gov.au |
BY DAKOTA TAIT
A pain-free diabetes test developed at the University of Newcastle is set to change millions of lives around the world, after receiving $6 million in funding from the Federal Government to help get the product to market.
Led by Professor Paul Dastoor, a team at the Centre for Organic Electronics worked to create a biosensor which tests saliva for glucose, in place of the traditional finger-prick blood tests used since the 1960s.
The biosensors are the size of a stick of chewing gum and use the reaction between saliva and a natural enzyme to produce an electrical current and detect tiny levels of glucose - and all you have to do is lick it.
"It's been said that non-invasive glucose testing is the Holy Grail of this entire area," Prof Dastoor said.
"We have nearly 500 million people with diabetes - and if you've got diabetes, you know what you have to do - you have to stab yourself four to ten times a day. What we've been able to do now is to develop a technology where you just need to use your saliva."
The sensors are currently being manufactured on a small-scale at the University, but the technology is printed using electronic ink and has the potential to be produced at a larger scale.
It's hoped the Federal grant will be enough to get the first manufacturing facility for the sensors up and running, with the production line set to start by at least 2023.
The technology is also the first University of Newcastle invention to show up on an international stock exchange.
Prof Dastoor says he's "super excited" to see the sensors hit the shelves, as well as their potential to shake up other industries and areas.
"In terms of other applications, this printed biosensor technology is a platform technology," Prof Dastoor said.
"For example, we're already working to with colleagues at Harvard University on a test, if you like, for COVID, for COVID antibodies. And we're now heading towards tests for biomarkers for cancer, for hormones, and for allergens."
BY DAKOTA TAIT
Researchers at the Hunter Medical Research Institute are now recruiting participants for a world-first clinical trial to help methamphetamine addicts break their dependence with an existing drug.
The LiMA study hopes to find out if a high dosage of lisdexamfetamine, currently approved to treat ADHD, could be effective in reducing methamphetamine use and easing cravings and withdrawal symptoms.
Professor Adrian Dunlop, Director of Drug and Alcohol Clinical Services at Hunter New England Health, says the research could be helpful in curbing Australia's high rates of ice abuse.
"We've consistently seen methamphetamine users presenting for treatment over the past decade in Newcastle and across the Hunter region," Prof Dunlop said.
"While counselling is effective for many people with less problematic methamphetamine use, we currently don't have a proven medication treatment for severe methamphetamine dependence."
Dexamphetamine, of which lisdexamfetamine is a slow release form, has already had promising results in treating ice dependence.
But Lisdexamfetamine has a slower onset of action and is much more difficult for the body to use in a non-medical way.
"If you crush up the drug and inject it, you are not going to get a rush because it still has to be turned into dexamphetamine in your blood," Prof Dunlop said.
The study has already recruited 142 people and is looking for 38 more.
Participants will receive either lisdexamfetamine or a placebo medication, as well as access to counselling services.
People interested in taking part can contact Hunter New England Health Drug and Alcohol Clinical Services at 0417656352 or 0438065230, or on the study's website at www.limastudy.info.
![]() |
Electrical Engineering Graduate Sam Parker poses with his final year project. |